Skip to main content
. 2022 Dec 8;13:1051673. doi: 10.3389/fimmu.2022.1051673

Figure 5.

Figure 5

Immunotherapy of 67 patients with anti-interferon-γ autoantibodies positivity. (A) The number of changes in the AIGA titer of anti-interferon-γ autoantibodies positivity patients after immunotherapy. (B) The outcome of patients with anti-interferon-γ autoantibodies positivity after immunotherapy. CTX, cyclophosphamide; MP, methylprednisolone; RTX, rituximab.